Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-02-03 Smith Robin L Director Exercise or conversion +1,200 $7.65 $9K 1,900
2017-02-03 Smith Robin L Director Exercise or conversion · Stock Option (Right to Buy) −1,200 0
2016-06-15 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2015-08-06 Smith Robin L Director Exercise or conversion +4,125 5,500
2015-08-06 Smith Robin L Director Grant or award +5,000 10,500
2015-08-06 Smith Robin L Director Exercise or conversion · Restricted Stock Units −4,125 0
2015-08-06 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2015-07-17 Smith Robin L Director Exercise or conversion +1,375 1,375
2015-07-17 Smith Robin L Director Exercise or conversion · Restricted Stock Units −1,375 4,125
2014-07-17 Smith Robin L Director Grant or award · Stock Option (right to buy) +6,000 6,000
2014-07-17 Smith Robin L Director Grant or award · Restricted Stock Units +5,500 5,500

Page 1 of 1 · 11 trades